Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: A4HPX3
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 17 |
GO:0006793 | phosphorus metabolic process | 3 | 17 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 17 |
GO:0006807 | nitrogen compound metabolic process | 2 | 17 |
GO:0008152 | metabolic process | 1 | 17 |
GO:0009987 | cellular process | 1 | 17 |
GO:0016310 | phosphorylation | 5 | 17 |
GO:0019538 | protein metabolic process | 3 | 17 |
GO:0036211 | protein modification process | 4 | 17 |
GO:0043170 | macromolecule metabolic process | 3 | 17 |
GO:0043412 | macromolecule modification | 4 | 17 |
GO:0044237 | cellular metabolic process | 2 | 17 |
GO:0044238 | primary metabolic process | 2 | 17 |
GO:0071704 | organic substance metabolic process | 2 | 17 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 17 |
GO:0003824 | catalytic activity | 1 | 17 |
GO:0004672 | protein kinase activity | 3 | 17 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 17 |
GO:0004683 | calmodulin-dependent protein kinase activity | 5 | 6 |
GO:0005488 | binding | 1 | 17 |
GO:0005524 | ATP binding | 5 | 17 |
GO:0016301 | kinase activity | 4 | 17 |
GO:0016740 | transferase activity | 2 | 17 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 17 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 17 |
GO:0016905 | myosin heavy chain kinase activity | 6 | 6 |
GO:0017076 | purine nucleotide binding | 4 | 17 |
GO:0030554 | adenyl nucleotide binding | 5 | 17 |
GO:0032553 | ribonucleotide binding | 3 | 17 |
GO:0032555 | purine ribonucleotide binding | 4 | 17 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 17 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 17 |
GO:0036094 | small molecule binding | 2 | 17 |
GO:0043167 | ion binding | 2 | 17 |
GO:0043168 | anion binding | 3 | 17 |
GO:0097159 | organic cyclic compound binding | 2 | 17 |
GO:0097367 | carbohydrate derivative binding | 2 | 17 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 17 |
GO:1901265 | nucleoside phosphate binding | 3 | 17 |
GO:1901363 | heterocyclic compound binding | 2 | 17 |
GO:0003676 | nucleic acid binding | 3 | 5 |
GO:0003746 | translation elongation factor activity | 4 | 5 |
GO:0008135 | translation factor activity, RNA binding | 3 | 5 |
GO:0045182 | translation regulator activity | 1 | 5 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 269 | 273 | PF00656 | 0.329 |
CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.304 |
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.340 |
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.381 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.274 |
CLV_PCSK_KEX2_1 | 145 | 147 | PF00082 | 0.345 |
CLV_PCSK_KEX2_1 | 250 | 252 | PF00082 | 0.515 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.430 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.423 |
CLV_PCSK_PC1ET2_1 | 145 | 147 | PF00082 | 0.334 |
CLV_PCSK_PC1ET2_1 | 250 | 252 | PF00082 | 0.345 |
CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.459 |
CLV_PCSK_PC7_1 | 246 | 252 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.371 |
DEG_APCC_DBOX_1 | 59 | 67 | PF00400 | 0.338 |
DEG_SPOP_SBC_1 | 138 | 142 | PF00917 | 0.422 |
DOC_CYCLIN_RxL_1 | 215 | 226 | PF00134 | 0.299 |
DOC_MAPK_gen_1 | 248 | 257 | PF00069 | 0.346 |
DOC_MAPK_MEF2A_6 | 236 | 245 | PF00069 | 0.507 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.422 |
DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.473 |
DOC_USP7_UBL2_3 | 206 | 210 | PF12436 | 0.372 |
DOC_USP7_UBL2_3 | 233 | 237 | PF12436 | 0.458 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.369 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.331 |
LIG_BRCT_BRCA1_2 | 116 | 122 | PF00533 | 0.331 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.300 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.297 |
LIG_FHA_2 | 159 | 165 | PF00498 | 0.342 |
LIG_FHA_2 | 269 | 275 | PF00498 | 0.443 |
LIG_IBAR_NPY_1 | 240 | 242 | PF08397 | 0.334 |
LIG_LIR_Gen_1 | 155 | 163 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 125 | 130 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 239 | 245 | PF02991 | 0.598 |
LIG_LIR_Nem_3 | 95 | 100 | PF02991 | 0.380 |
LIG_PCNA_yPIPBox_3 | 201 | 210 | PF02747 | 0.422 |
LIG_Pex14_2 | 54 | 58 | PF04695 | 0.309 |
LIG_REV1ctd_RIR_1 | 95 | 105 | PF16727 | 0.331 |
LIG_SH2_GRB2like | 41 | 44 | PF00017 | 0.416 |
LIG_SH2_GRB2like | 90 | 93 | PF00017 | 0.285 |
LIG_SH2_STAP1 | 278 | 282 | PF00017 | 0.589 |
LIG_SH2_STAT3 | 100 | 103 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.422 |
LIG_SH3_3 | 108 | 114 | PF00018 | 0.290 |
LIG_SH3_3 | 258 | 264 | PF00018 | 0.429 |
LIG_SH3_3 | 63 | 69 | PF00018 | 0.362 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.380 |
LIG_TRAF2_1 | 266 | 269 | PF00917 | 0.514 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.344 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.331 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.333 |
MOD_CK2_1 | 137 | 143 | PF00069 | 0.416 |
MOD_CK2_1 | 158 | 164 | PF00069 | 0.361 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.483 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.387 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.361 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.351 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.326 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.337 |
MOD_GSK3_1 | 223 | 230 | PF00069 | 0.376 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.409 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.399 |
MOD_N-GLC_1 | 69 | 74 | PF02516 | 0.404 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.325 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.530 |
MOD_PIKK_1 | 145 | 151 | PF00454 | 0.211 |
MOD_PIKK_1 | 280 | 286 | PF00454 | 0.367 |
MOD_PIKK_1 | 99 | 105 | PF00454 | 0.353 |
MOD_PKA_1 | 145 | 151 | PF00069 | 0.445 |
MOD_PKA_2 | 118 | 124 | PF00069 | 0.489 |
MOD_PKA_2 | 145 | 151 | PF00069 | 0.445 |
MOD_PKA_2 | 82 | 88 | PF00069 | 0.419 |
MOD_Plk_1 | 69 | 75 | PF00069 | 0.422 |
MOD_Plk_2-3 | 268 | 274 | PF00069 | 0.564 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.325 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.369 |
MOD_SUMO_rev_2 | 129 | 138 | PF00179 | 0.369 |
MOD_SUMO_rev_2 | 189 | 194 | PF00179 | 0.379 |
MOD_SUMO_rev_2 | 232 | 238 | PF00179 | 0.570 |
MOD_SUMO_rev_2 | 38 | 47 | PF00179 | 0.183 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.354 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.476 |
TRG_ER_diArg_1 | 255 | 258 | PF00400 | 0.514 |
TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.430 |
TRG_NLS_Bipartite_1 | 135 | 149 | PF00514 | 0.289 |
TRG_Pf-PMV_PEXEL_1 | 218 | 223 | PF00026 | 0.506 |
TRG_Pf-PMV_PEXEL_1 | 265 | 269 | PF00026 | 0.528 |
TRG_Pf-PMV_PEXEL_1 | 31 | 35 | PF00026 | 0.302 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1L4 | Leptomonas seymouri | 80% | 90% |
A0A0S4J072 | Bodo saltans | 60% | 67% |
A0A1X0NJ27 | Trypanosomatidae | 59% | 82% |
A0A3Q8IGH4 | Leishmania donovani | 88% | 86% |
A0A3Q8IJS7 | Leishmania donovani | 57% | 78% |
A4HPX1 | Leishmania braziliensis | 58% | 100% |
A4IDN3 | Leishmania infantum | 57% | 78% |
A4IDN5 | Leishmania infantum | 88% | 86% |
C9ZME6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 88% |
C9ZWN7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 88% |
E9ATN7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 56% | 78% |
E9ATN9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 86% |
Q4Q0U3 | Leishmania major | 87% | 100% |
Q4Q0W0 | Leishmania major | 57% | 100% |
V5AN54 | Trypanosoma cruzi | 60% | 87% |